CCTV Prescription Drug Sales India: Draft Rule
CCTV prescription drug sales India is now a live policy question. On 8 September 2026, the Union Health Ministry issued draft notification G.S.R. 791(E), which proposes mandatory CCTV at retail medical stores that sell Schedule H, H1 and X medicines. The draft is open for public comment and is not yet law. This post explains what it proposes, what is still unsettled, and which pharmacy records already have to be kept. It also looks at where clinic dispensing software fits, and where it does not.
What the CCTV Prescription Drug Sales Draft Proposes
Schedule H, H1 and X medicines are the ones that, as Utkarsh puts it, can be sold only against a valid prescription. The draft would amend the Drugs Rules, 1945. Based on the press reports we opened, its main points are:
- Scope: It covers Schedule H, H1 and X medicines. Dharmakshethra notes that the proposal “does not convert these medicines into newly controlled drugs.”
- Where cameras go: Prescription drugs supplied other than through wholesale dealing would have to be sold under a CCTV system “installed and maintained on the licensed premises,” according to the Tribune. Wholesale transactions are not covered.
- Footage: Recordings would have to be kept for at least three months, as the Tribune and India Observers both report.
- Legal form: India Observers describes a new clause under Rule 65 of the Drugs Rules, with the rule taking effect on a date the government sets after publication.

Why the Health Ministry Wants Cameras at the Counter
The stated aim is to stop medicines reaching patients without a valid prescription. Dharmakshethra quotes the ministry saying that surveillance would “strengthen monitoring of the sale and distribution of Schedule H, H1 and X medicines” and help “curb unauthorised access and sales without valid prescriptions.”
The Tribune describes the problem as prescription-only medicines still being sold over the counter at some pharmacies. In its account, footage would give regulators a verifiable record if they investigate whether a sale followed the rules. India Observers adds that the government presents the measure as a step toward transparency and accountability. The same Tribune report links the proposal to India’s antimicrobial resistance problem, which is a wider public-health concern rather than a finding about any single pharmacy.
For clinics, the practical point is that the draft targets the retail sale itself, the moment a medicine leaves a counter. That is where a prescription, a patient and a batch come together, so it is also where a clinic’s records matter most.
What Is Still Unsettled
The draft is not law, and the sources we read do not agree on every detail.
The comment period is the first open question. Tribune reports that the ministry invited objections and suggestions for 30 days. India Observers says the 30 days run from publication of the amendment in the Official Gazette. Dharmakshethra and Utkarsh give no deadline. We could not open the gazette text or the CDSCO notification pages while preparing this post, so the exact wording and the start of the comment period need to be checked on the official gazette before anyone relies on them.
The reports also leave out operational detail. None of the sources we read sets out camera specifications, who may access footage, or what happens to it after the three-month minimum. No source we read gives a commencement date. Any clinic planning around the draft should treat these as open questions rather than settled requirements.

Records Pharmacies Already Keep
Even without the new draft, these medicines already carry a paper trail. A pharmacy compliance explainer on Healthix, dated 5 November 2026, summarises the register rules under the consolidated Drugs and Cosmetics Rules. It is a secondary source, so the rule text should be checked before anyone relies on the details. According to that explainer:
Schedule H1 supplies must be recorded in a separate register at the time of supply. Each entry includes the prescriber’s name and address, the patient’s name, the drug and the quantity. The explainer says these records are kept for three years and must be open for inspection.
For general Schedule H supplies, the register also records the manufacturer, batch, expiry date and the pharmacist’s signature, and is kept for at least two years from the last entry. Schedule X sales use a duplicate prescription and a bound register with numbered pages.
As the draft is reported, CCTV would be added on top of these requirements. None of the reports we read says it would replace them.
Where Pharmacy Software Fits
Clinics that run a dispensing counter have a practical stake in how their sale records are kept. InstaPraxis includes a pharmacy point-of-sale inside its clinic ERP. It covers prescription-to-bill, sales and returns, batch management, barcode lookup, dispense warnings, a daily cash close and CSV export. Used properly, these features help a clinic tie a sale to a prescription and a batch, and export the records for its own review.
Software is not a camera, though. The InstaPraxis feature list does not include CCTV recording, and it does not describe printing the statutory registers set out above. Whether a particular premises needs cameras, or a particular register, is a question for the clinic’s licensing authority and its pharmacist. Treat the software as a support tool for accurate records, not as a compliance guarantee.
A simple way to prepare now is to confirm which of your medicines fall under Schedules H, H1 and X, check that each dispensed item links back to a prescription and a batch, and keep your paper or digital registers complete. Then review the official gazette once the comment period is clear. Our other healthtech guides are on the InstaDataHelp blog.
Watch: Check If a Prescription QR Code Is Genuine in India: What to Verify
Watch on YouTube · More tutorials on our channel
Frequently Asked Questions
Is CCTV for prescription drug sales already law in India?
No. As reported, G.S.R. 791(E) is a draft issued on 8 September 2026. The reports we read describe it as open for objections and suggestions, and none describes it as final.
Would wholesalers need CCTV under the draft?
No. The press reports we read say wholesale dealing is excluded. The proposed requirement applies to prescription drug supplies made other than through wholesale dealing, at licensed premises.
How long would pharmacies keep CCTV footage?
The reports we read say at least three months. The draft text itself should be checked on the official gazette before relying on that figure.
Does InstaPraxis record CCTV footage?
No. The InstaPraxis pharmacy module covers sales, batches, returns and reporting. It does not include video recording.
Sources
- Tribune: CCTVs mooted to track prescription drug sale, updated 18 September 2026
- India Observers: CCTV rules for licensed pharmacies proposed by the Health Ministry, 18 September 2026
- Dharmakshethra: Centre proposes mandatory CCTV at medical stores to curb unauthorised sale of prescription drugs, 18 September 2026
- Utkarsh: Union Health Ministry proposes amendments to Drugs Rules, 1945, updated 17 September 2026
- Healthix: Schedule H, H1 and X drugs register rules for hospital pharmacies, 5 November 2026 (secondary explainer)
If your clinic runs a dispensing counter, explore InstaPraxis to see how its pharmacy module keeps sales tied to prescriptions and batches. InstaPraxis is ₹399 per doctor per month.
